Wellgistics Health, Inc. Common Stock earnings per share and revenue
On 20 de nov. de 2025, WGRX reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
What were Wellgistics Health, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Wellgistics Health, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Wellgistics Health, Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Wellgistics Health, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for Wellgistics Health, Inc. Common Stock's next earnings report?
Based on --
analistas, Wellgistics Health, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.